A2 Bio
$80.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
A2 Bio is currently valued at $280.0M as of January 9, 2025. The company has raised a total of $352.9M in funding.
Capital Efficiency
With a capital efficiency ratio of 0.79x, A2 Bio has achieved a valuation that is 0.79 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
A2 Bio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is A2 Bio Worth in 2025?
As of 2025, A2 Bio is valued at $280.0M, based on the company's Later Stage VC funding round in January 9, 2025. This valuation positions A2 Bio as one of the leading private companies in the sector.
A2 Bio Valuation History
A2 Bio's funding history demonstrates steady growth and investor confidence.
How A2 Bio Valuation is Determined
Private company valuations like A2 Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
A2 Bio Valuation FAQs
Is A2 Bio profitable?
A2 Bio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does A2 Bio's valuation compare to competitors?
A2 Bio is valued at $280.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will A2 Bio IPO?
A2 Bio has not announced plans for an initial public offering. Until an IPO, investors can access A2 Bio shares through secondary market platforms.